Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Griffith University reports development of antiviral agents

March 30, 2016

Spero Therapeutics describes antibiotic agents

March 30, 2016

Sanofi obtains Japanese approval of primaquine for malaria

March 30, 2016

New dose and formulation of Malarone combination tablets receive Japanese approval

March 29, 2016

The potential of dispiro-cycloalkanone compounds as antifilarial drug candidates

March 29, 2016

Janssen R&D Ireland presents anti-influenza agents

March 29, 2016

Hong Kong Polytechnic University develops antibacterial agents

March 29, 2016

Roche submits Elecsys BRAHMS PCT sepsis assay to the FDA

March 24, 2016

Host cell protein complex identified as a potential HBV therapy target

March 24, 2016

Profounda announces launch of Impavido in the U.S.

March 24, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...